Latest Liver Disease News

Page 2 of 2

Vectus Validates VB0004 Safety, Cuts Costs, Eyes China Licensing Deals

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

Ada Torres

30 Apr 2025

Browse the archive

Full archive

Sept 2026 Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026

Top